Information

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm

Key Opinions in Medicine

  • Register
  • Login
Skip to content
  • Home
  • Issues
    • Allergy & Immunology
    • Cardiology
    • Conference
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes & Endocrinology
    • Gastroenterology
    • General Medicine
    • Haematology
    • Hepatology
    • Infectious Diseases
    • Metabolic Disorders
    • Neurology
    • Nursing
    • Obstetrics & Gynaecology
    • Oncology
    • Paediatrics
    • Psychiatry
    • Rheumatology
    • Surgery Insights
    • Urology
  • About
  • Contact
  • Register
  • Login

Figure-3

Published November 30, 2025 at 957 × 653 in Clinical management of COVID-19: what do GPs need to know?.
← Previous
PBS, Pharmaceutical Benefits Scheme; SSRI, selective serotonin-reuptake inhibitor; ACE, angiotensin-converting enzyme Australian Institute of Health and Welfare (2024). Medicines in the health system. Available at: https://www.aihw.gov.au/reports/medicines/medicines-in-thehealth- system [Accessed 15 September 2025] University of Liverpool (2025). COVID-19 Drug Interactions. Available at: Liverpool COVID-19 Interactions [Accessed 15 September 2025]

Popular Issues

Konkurrenz für den Therapiestandard

MOVICOL® (PEG3350 plus electrolytes): 20 years of evidence-based use

Register

Register

Sign up for free access to Wiley’s Key Opinions in Medicine to keep up to date with latest trends and key developments within your specialty area.

Share

Copyright © 2000-2026 by John Wiley & Sons, Inc., or related companies. All rights reserved.
Review our privacy policy. Cookie Preferences.
Web design and marketing agency Leamington Spa